Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (211-220 of 361) with videos related to

Pageof 37
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 23, 2021
Index Admission and Thirty-Day Readmission Outcomes of Patients With Cancer Presenting With STEMIMohammed Osman, Mina M Benjamin, Sudarshan Balla, et al.
Clinical Chemistry|March 1, 1983
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9B C Del Villano, S Brennan, P Brock, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2025
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitorsS V Liu, R Dziadziuszko, S Viteri, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Applied Clinical Informatics|July 15, 2015
The Accuracy of an Electronic Pulmonary Embolism Severity Index Auto-Populated from the Electronic Health Record: Setting the stage for computerized clinical decision supportD R Vinson, J E Morley, J Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group TrialMaria E Cabanillas, Jonas A de Souza, Susan Geyer, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Translational Vision Science & Technology|August 25, 2020
Quantifiable In Vivo Imaging Biomarkers of Retinal Regeneration by Photoreceptor Cell TransplantationYing V Liu, Simrat K Sodhi, Gilbert Xue, et al.
Clinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.
Pageof 37

Showing results (211-220 of 361) with videos related to

Sort By:
Pageof 37
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 23, 2021
Index Admission and Thirty-Day Readmission Outcomes of Patients With Cancer Presenting With STEMIMohammed Osman, Mina M Benjamin, Sudarshan Balla, et al.
Clinical Chemistry|March 1, 1983
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9B C Del Villano, S Brennan, P Brock, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2025
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitorsS V Liu, R Dziadziuszko, S Viteri, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Applied Clinical Informatics|July 15, 2015
The Accuracy of an Electronic Pulmonary Embolism Severity Index Auto-Populated from the Electronic Health Record: Setting the stage for computerized clinical decision supportD R Vinson, J E Morley, J Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group TrialMaria E Cabanillas, Jonas A de Souza, Susan Geyer, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Translational Vision Science & Technology|August 25, 2020
Quantifiable In Vivo Imaging Biomarkers of Retinal Regeneration by Photoreceptor Cell TransplantationYing V Liu, Simrat K Sodhi, Gilbert Xue, et al.
Clinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.
Pageof 37